Public Company News
LightInTheBox Reports Fourth Quarter and Full Year 2025 Financial Results
Record Full year Profit of $8.3 million Record Quarterly Profit of $3.3 Million Delivers Seventh Consecutive Profitable Quarter Regains Quarterly Revenue Growth SINGAPORE, March 24, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consu...
2026-03-24 19:00
6491
Robo.ai Initiates Revenue Recognition for Intelligent Data Business and Advances Tens of Thousands of Hours of Capacity Cooperation Across the Middle East and Asia
DUBAI, UAE, March 24, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO) (the "Company" or "Robo.ai") today announced the capacity expansion plan for its intelligent data business segment. Following the delivery of its initial batch of real-world interaction data and the initiation of the revenue r...
2026-03-24 18:57
3871
Insilico Medicine and ASKA Pharmaceutical Expand Partnership to Discover Novel Targets for Women's Health
CAMBRIDGE, Mass., March 24, 2026 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized p...
2026-03-24 18:29
3678
GCCL Showcases RSV FRNT Research and Integrated Bioanalytical Capabilities at World Vaccine Congress 2026
YONGIN, South Korea, March 24, 2026 /PRNewswire/ -- GCCL Co., Ltd. (GCCL), a global clinical trial laboratory services provider, announced that it will attend World Vaccine Congress 2026 (WVC 2026), taking place from March 30 to April 2 in Washington, D.C., where it will operate an exhibition boo...
2026-03-24 17:35
3399
Cheetah Mobile Announces Fourth Quarter and Fiscal Year 2025 Unaudited Consolidated Financial Results
AI and Others revenue grew 84.7% year over year and accounted for 46.5% of total revenue in 2025 BEIJING, March 24, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced its unaudite...
2026-03-24 16:30
4574
HOY Unveils a Powerhouse Line-up with Cross-Industry Partnerships to Usher in a Bold New Chapter
Exclusive Asian Games Broadcast Continues for Eighth Consecutive Years HONG KONG, March 24, 2026 /PRNewswire/ -- HOY, the free–to–air television channel underi–CABLE Communications Limited (Stock Code: 1097), unveiled its 2026 program slate at FilmArt, marking a major step forward into a compreh...
2026-03-24 15:28
2780
Tuya Smart Launches TuyaClaw--Still the Same "Claw," but Actually Does Housework
NEW YORK, March 24, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform service provider, has officially launched TuyaClaw, the AI agent that connects the digital and physical worlds. Built on the OpenClaw architecture, it significantly reduces deployment barriers...
2026-03-24 14:10
3591
LEIFRAS Co., Ltd. Releases Two Business Introduction Videos Visualizing "Community Transfer of Club Activities" and "Sports Therapy"
Bringing to Life How Schools, Homes, and Communities Are Changing Across Japan Through Real Insights from the Field TOKYO, March 23, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community eng...
2026-03-24 09:00
3911
The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China
* 73% of participants achieved Q16W dosing interval; Furthermore, nearly 60% of the participants held the potential to extend the dosing interval to Q20W. SAN FRANCISCO and SUZHOU, China, March 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharma...
2026-03-24 08:00
4553
WuXi XDC Delivers Exceptional Performance in 2025, Reinforcing Global Leadership in Bioconjugate CRDMO
* Revenue increased by 46.7% YoY to RMB 5,944 million * Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 36.0%, a 5.4 percentage points increase compared to 2024 * Adjusted net profit increased by 69.9% YoY to RMB 1,559 million, with its margin of 26.2%, a 3.6 percen...
2026-03-23 21:15
5724
Insilico Medicine Launches PandaClaw: Empowering Biologists with Agentic AI for Therapeutic Discovery
CAMBRIDGE, Mass., March 23, 2026 /PRNewswire/ -- Insilico Medicine
("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven
drug discovery company, today announced the launch ofPandaClaw, a
transformative new feature of thePandaOmics
2026-03-23 20:30
5089
Roborock Launches Saros 20 in North America -- Engineered for Complex, High-End Homes and Real-World AI Cleaning
HONG KONG, March 23, 2026 /PRNewswire/ -- After unveiling its long-term vision
of embodied intelligence at CES 2026 with Saros Rover,Roborock
2026-03-23 20:00
5968
ECARX Strengthens Global Leadership Team with Appointment of Dylan D. Jeng as Chief Financial Officer
LONDON, March 23, 2026 /PRNewswire/ -- ECARX Holdings, Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced the appointment ofDylan D. Jeng as Chief Financial Officer (CFO), effective immediately. In his role as CFO, Dylan Jeng will be based in ECARX's ...
2026-03-23 19:00
8288
Fasoo and Konsilix Agree to Form Symbologic, an Enterprise AI Company
BETHESDA, Md., March 23, 2026 /PRNewswire/ -- Ahead of the RSAC 2026 Conference,
Fasoo
2026-03-23 18:08
5429
Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Second Quarter of Fiscal 2026 Ended December 31, 2025
SHANGHAI, March 23, 2026 /PRNewswire/ -- Gamehaus Holdings Inc. ("Gamehaus" or the "Company") (Nasdaq: GMHS), a technology-driven mobile game publisher, today announced its unaudited financial results for the second quarter of fiscal year 2026 ended December 31, 2025. Second Quarter of Fiscal Ye...
2026-03-23 18:00
6786
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 22, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and immune-oncology, today announ...
2026-03-23 11:14
4610
Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study
SAN FRANCISCO and SUZHOU, China, March 22, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
2026-03-23 08:00
3736
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target
SHANGHAI, March 21, 2026 /PRNewswire/ -- On the occasion of World Water Day,
WuXi Biologics reaffirms its commitment to sustainability through responsible
operations and efficient, circular water‑use practices that reduce
environmental impact.
2026-03-22 09:30
3972
LG Display becomes world's first to mass-produce 1-120Hz laptop panel
SEOUL, South Korea, March 21, 2026 /PRNewswire/ -- LG Display, the world's
leading innovator of display technologies, today announced that it is beginning
the world's first-ever mass production of an LCD panel for laptops equipped
with its Oxide 1Hz technology.
2026-03-22 09:00
2398
Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)
* Treatment with ZEGFROVY® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over platinum-containing chemo doublet * WU-KONG 28 is the first and only phase 3 study to demonstrate meaningful benefits with an oral, once daily, chemo-...
2026-03-21 19:26
7139
Week's Top Stories
Most Reposted
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 297 media titles]
2026-05-12 10:15
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 295 media titles]
2026-05-11 16:20
Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 292 media titles]
2026-05-12 10:00Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 285 media titles]
2026-05-12 14:00
Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 284 media titles]
2026-05-15 17:00
Most Read
Luvme Introduces First-Ever Human Hair Base Braided Wig OwnScalp™, Bringing Salon-Like Braids into Everyday Life
2026-05-09 17:57
6736
Cloopen Files Annual Report on Form 20-F for Fiscal 2025
2026-05-09 04:30
6688
Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
2026-05-11 16:20
6215
